Skip to main content

Table 2 Knowledge items for carrier screening and aneuploidy screening

From: Decision-making for prenatal genetic screening: how will pregnant women navigate a growing number of aneuploidy and carrier screening options?

Baseline knowledge of Carrier Screening and Aneuploidy Screening

Knowledge of:

Carrier

Aneuploidy

Overall score median [Q1, Q3]

0.58 [0.46, 0.75]

0.55 [0.40, 0.75]

Overall score mean ± sd

0.59 ± 0.18

0.55 ± 0.23

 

% (N) correctly answered

% (N) correctly answered

Conditions recommended for screening

Cystic fibrosis 43.8% (88)

Trisomy 21,125 (62.2%)

SMA 33.8% (68)

Trisomy 18,177 (48.8%)

Thalassemia 26.4% (5)

Trisomy 13 85 (42.3%)

Sickle cell 39.3% (79)

Turner 53 (26.4%)

Klinefelter 44 (21.9%)

Etiology of recessive condition or aneuploidy condition

30.8% (62)

81.6% (164)

Recommended action for a positive screen result

53.2% (107)

57.7% (116)

Implications for future pregnancies

34.8% (70)

80.6% (162)

Recommendation for universal offering of screen

46.3% (93)

45.3% (91)

Etiology of the genetic condition

51.2% (103)

69.2% (139)

Reproductive History risk for condition

85.1% (171)

82.6% (166)

Maternal age as a risk factor for a condition

(No increase with age)

23.9% (48)

(Increase with age)

79.1% (159)

Inheritance (heritable or sporadic condition)

34.8% (70)

27.4% (55)